Advertisement
Advertisement

PHR

PHR logo

Phreesia, Inc.

11.44
USD
Sponsored
-0.14
-1.21%
Aug 18, 15:59 UTC -4
Closed
exchange

After-Market

11.27

-0.17
-1.49%

PHR Earnings Reports

Positive Surprise Ratio

PHR beat 24 of 28 last estimates.

86%

Next Report

Date of Next Report
Sep 02, 2026
Estimate for Q2 27 (Revenue/ EPS)
$130.36M
/
$0.08
Implied change from Q1 27 (Revenue/ EPS)
-0.44%
/
+60.00%
Implied change from Q2 26 (Revenue/ EPS)
+11.18%
/
+700.00%

Phreesia, Inc. earnings per share and revenue

On May 27, 2026, PHR reported earnings of 0.05 USD per share (EPS) for Q1 27, beating the estimate of 0.01 USD, resulting in a 323.73% surprise. Revenue reached 130.94 million, compared to an expected 131.37 million, with a -0.33% difference. The market reacted with a +3.50% price change (close before vs. close after earnings).
Looking ahead to Q2 27, 14 analysts forecast an EPS of 0.08 USD, with revenue projected to reach 130.36 million USD, implying an increase of 60.00% EPS, and decrease of -0.44% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Claritev Corporation
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$4.21
Actual
-$3.49
Surprise
+17.12%
logo
Senseonics Holdings, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.63
Actual
-$0.63
Surprise
+1.13%
logo
CapsoVision, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.13
Actual
-$0.15
Surprise
-12.02%
logo
Insight Molecular Diagnostics Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.24
Actual
-$0.23
Surprise
+7.67%
logo
CareCloud, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.06
Actual
$0.06
Surprise
-7.12%
logo
Neuraxis, Inc.
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$0.32
Actual
-$0.19
Surprise
+41.79%
logo
P3 Health Partners Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$1.93
Actual
-$0.63
Surprise
+67.41%
logo
Hims & Hers Health, Inc.
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.01
Actual
-$0.10
Surprise
-599.30%
logo
Heartflow, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.13
Actual
-$0.07
Surprise
+48.68%
logo
MDxHealth SA Ordinary Shares
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.19
Actual
-$0.18
Surprise
+9.04%
FAQ
For Q1 2027, Phreesia, Inc. reported EPS of $0.05, beating estimates by 323.73%, and revenue of $130.94M, -0.33% below expectations.
The stock price moved up 3.5%, changed from $9.13 before the earnings release to $9.45 the day after.
The next earning report is scheduled for Sep 02, 2026.
Based on 14 analysts, Phreesia, Inc. is expected to report EPS of $0.08 and revenue of $130.36M for Q2 2027.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement